Your browser doesn't support javascript.
loading
Testing Denmark: A Danish nationwide surveillance study of COVID-19
Kamille Fogh; Jarl E Strange; Bibi FSS Scharff; Alexandra RR Eriksen; Rasmus B Hasselbalch; Henning Bundgaard; Susanne D Nielsen; Charlotte S Joergensen; Christian Erikstrup; Jakob Norsk; Pernille B Nielsen; Jonas H Kristensen; Lars Oestergaard; Svend Ellermann-Eriksen; Berit Andersen; Henrik Nielsen; Isik S Johansen; Lothar Wiese; Lone Simonsen; Thea K Fischer; Fredrik Folke; Freddy Lippert; Sisse R Ostrowski; Thomas Benfield; Kaare Moelbak; Steen Ethelberg; Anders Koch; Ute W Sonksen; Anne-Marie Vangsted; Tyra Grove Krause; Anders Formsgaard; Henrik Ullum; Robert Skov; Kasper Iversen.
Afiliação
  • Kamille Fogh; Department of Cardiology and Department of Emergency Medicine, Herlev and Gentofte Hospital, Denmark
  • Jarl E Strange; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte
  • Bibi FSS Scharff; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Alexandra RR Eriksen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Rasmus B Hasselbalch; Department of Cardiology and Department of Emergency Medicine, Herlev and Gentofte Hospital, Denmark
  • Henning Bundgaard; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Susanne D Nielsen; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Charlotte S Joergensen; Statens Serum Institut, Copenhagen, Denmark
  • Christian Erikstrup; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark
  • Jakob Norsk; Department of Cardiology and Department of Emergency Medicine, Herlev and Gentofte Hospital, Denmark
  • Pernille B Nielsen; Department of Cardiology and Department of Emergency Medicine, Herlev and Gentofte Hospital, Denmark
  • Jonas H Kristensen; Department of Cardiology and Department of Emergency Medicine, Herlev and Gentofte Hospital, Denmark
  • Lars Oestergaard; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
  • Svend Ellermann-Eriksen; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark
  • Berit Andersen; University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark
  • Henrik Nielsen; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
  • Isik S Johansen; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
  • Lothar Wiese; Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark
  • Lone Simonsen; Department of Science and Environment, University of Roskilde, Denmark
  • Thea K Fischer; Department of Clinical Research, North Zealand Hospital, Hilleroed, Denmark
  • Fredrik Folke; Copenhagen Emergency Medical Services, Copenhagen, Denmark
  • Freddy Lippert; Copenhagen Emergency Medical Services, Copenhagen, Denmark
  • Sisse R Ostrowski; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Thomas Benfield; Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark
  • Kaare Moelbak; Statens Serum Institut, Copenhagen, Denmark
  • Steen Ethelberg; Statens Serum Institut, Copenhagen Denmark
  • Anders Koch; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark and Statens Serum Institut, Copenhagen Denmark
  • Ute W Sonksen; Statens Serum Institut, Copenhagen Denmark
  • Anne-Marie Vangsted; Statens Serum Institut, Copenhagen Denmark
  • Tyra Grove Krause; Statens Serum Institut, Copenhagen Denmark
  • Anders Formsgaard; Statens Serum Institut, Copenhagen Denmark
  • Henrik Ullum; Statens Serum Institut, Copenhagen Denmark
  • Robert Skov; Statens Serum Institut, Copenhagen Denmark
  • Kasper Iversen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21261777
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
BackgroundNational data on the spread of SARS-CoV-2 infection and knowledge on associated risk factors are important for understanding the course of the pandemic. "Testing Denmark" is a national large-scale epidemiological surveillance study of SARS-CoV-2 in the Danish population. MethodsBetween September and October 2020, approximately 1.3 million of 5.8 million Danish citizens (age > 15 years) were randomly invited to fill in an electronic questionnaire covering COVID-19 exposures and symptoms. The prevalence of SARS-CoV-2 antibodies was determined by Point-of Care rapid Test (POCT) distributed to participants home addresses. FindingsIn total 318,552 participants (24.5% invitees) completed the questionnaire and provided the result of the POCT. Of these, 2,519 (0.79%) were seropositive (median age 55 years) and women were more often seropositive than men, interquartile range (IQR) 42-64, 40.2% males. Of participants with a prior positive Polymerase Chain Reaction (PCR) test (n=1,828), 29.1% were seropositive in the POCT. Seropositivity increased with age irrespective of sex. Elderly participants (>61 years) reported less symptoms and had less frequently been tested for SARS-CoV-2 compared to younger participants. Seropositivity was associated with physical contact with SARS-CoV-2 infected individuals (Risk ratio (RR) 7.43, 95% CI 6.57-8.41) and in particular household members (RR 17.70, 95% CI 15.60-20.10). Home care workers had a higher risk of seropositivity (RR 2.09 (95% CI 1.58-2.78) as compared to office workers. Geographic population density was not associated to seropositivity. A high degree of compliance with national preventive recommendations was reported (e.g., > 80% use of face masks), but no difference was found between seropositive and seronegative participants. InterpretationThis study provides insight into the immunity of the Danish population seven to eight months after the first COVID-19 case in Denmark. The seroprevalence was lower than expected probably due to a low sensitivity of the POCT used or due to challenges relating to the reading of test results. Occupation or exposure in local communities were major routes of infection. As elderly participants were more often seropositive despite fewer symptoms and less PCR tests performed, more emphasis should be placed on testing this age group.
Licença
cc_by_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
...